TrianglePUBLICATIONS · 16572419
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2006 Jul
- First author
- Juergens C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Juergens C
- type
- Author
- name
- Weston C
- type
- Author
- name
- Lewis I
- type
- Author
- name
- Whelan J
- type
- Author
- name
- Paulussen M
- type
- Author
- name
- Oberlin O
- type
- Author
- name
- Michon J
- type
- Author
- name
- Zoubek A
- type
- Author
- name
- Juergens H
- type
- Author
- name
- Craft A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Juergens C
- type
- Author
- name
- Weston C
- type
- Author
- name
- Lewis I
- type
- Author
- name
- Whelan J
- type
- Author
- name
- Paulussen M
- type
- Author
- name
- Oberlin O
- type
- Author
- name
- Michon J
- type
- Author
- name
- Zoubek A
- type
- Author
- name
- Juergens H
- type
- Author
- name
- Craft A
- type
- Author
- bibliography ids
- nci-bib-8829e3f8d1ff1ef82b49cb3f
- book metadata
- content sha256
- fd28e50e1b4d95c2a8e8344ef31f2c2d0c2adcb0f4afd0405b3eb057ca32337e
- document type
- citation
- dois
- 10.1002/pbc.20820
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16572419
- immutable id
- pubmed:16572419@fd28e50e1b4d95c2a8e8344ef31f2c2d0c2adcb0f4afd0405b3eb057ca32337e
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- Source null
- issn print
- 1545-5009
- issue
- 1
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 22-9
- volume
- 47
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 16572419
- provenance
- batch id
- 19fb2de9a00882c94e86
- provider
- NCBI PubMed ESummary
- record sha256
- ec7c02d317289ac0fcfc04ca13d4bd62cf5d9b03aebcdc0b306d1aa1f2451255
- response sha256
- 4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
- retrieved at
- 2026-09-09T23:46:06.810486+00:00
- publication date
- display
- 2006 Jul
- precision
- month
- year
- 2006
- publication types
- Evaluation Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.
Preserved source evidence · Not medical advice